Cardiovascular disease is a global health problem with no geographic, gender, or socio-economic boundaries. Despite the tremendous advances in cardiac care made recently, including drugs, devices, and diagnostic innovations, many patients continue to die from heart disease or live with significant morbidity.
Challenges for the next decade include health promotion and disease prevention, obesity and diabetes, and acute heart failure and cardiorenal disease. We must broaden our scope of intervention to emphasize and extend preventive strategies, and translate our innovations into affirmative actions through carefully designed health policy strategies.
Artificial intelligence, along with genomic and proteomic biomarkers, promise to improve early detection and risk stratification, leading to a more personalized approach to cardiovascular medicine.